Log In/Sign Up
Your email has been sent.
GBI Biomanufacturing HQ 1850 NW 69th Ave 37,911 SF Industrial Building Plantation, FL 33313 $14,115,914 CAD ($372.34 CAD/SF) 6% Cap Rate
Investment Highlights
- TRIPLE-NET LEASE – SEVEN YEARS REMAINING: 100% leased to GBI Biomanufacturing through May 2033 with minimal landlord responsibilities.
- NEW FLORIDA STEM CELL LEGISLATION: Recent state law enabling regenerative treatments supports increased demand for stem cell manufacturing capacity.
- STRATEGIC BROWARD COUNTY LOCATION: Access to Sunrise Boulevard, Interstate 95, Florida’s Turnpike, and Ft. Lauderdale-Hollywood International Airport.
- VALUE-ADD OPPORTUNITY: Value-Add Opportunity - 9.84% Pro Forma Cap Rate.
- LIFE SCIENCES MANUFACTURING FACILITY: Specialized laboratory and biologics production infrastructure designed for pharmaceutical-grade operations.
- MARK-TO-MARKET OPPORTUNITY: Tenant currently pays below-market rent of $16.20/SF, compared to an estimated current market rent of $24.00/SF.
Executive Summary
GBI Biomanufacturing Headquarters, located at 1850 NW 69th Avenue in Plantation, Florida, a 38,000 square-foot biologics manufacturing and life sciences facility in Broward County. The property is fully leased to GBI Biomanufacturing, Inc., a contract development and manufacturing organization (CDMO) specializing in mammalian cell culture development and cGMP biologics production.
The asset is secured by a triple-net lease with approximately seven years of remaining term through May 31, 2033, providing stable cash flow while minimizing landlord responsibilities, as the tenant is responsible for taxes, insurance, operating expenses, and maintenance. The lease also includes 2.6 percent annual rent escalations, providing consistent income growth throughout the remaining primary lease term.
The facility supports highly specialized biologics manufacturing operations requiring tailored laboratory buildouts, advanced mechanical systems, and pharmaceutical-grade production infrastructure. GBI has invested approximately $26 million into the facility, demonstrating significant tenant commitment while creating substantial barriers to relocation.
The investment also offers a clear value-add component through the lease renewal structure. Upon the first renewal option, rent resets to 90 percent of prevailing market rent, representing over 40 percent mark-to-market rent upside based on current underwriting. This structure provides the ability to significantly increase income at the end of the primary term, producing a projected 9.84 percent cap rate in year seven.
Additionally, the property benefits from Florida’s recently enacted stem cell legislation, which allows certain regenerative treatments to be offered within the state and has helped increase demand for stem cell manufacturing capacity. GBI has indicated the expanded facility will support the production of up to one million stem cell units annually, positioning the asset within a rapidly growing segment of the biotechnology sector.
The asset is secured by a triple-net lease with approximately seven years of remaining term through May 31, 2033, providing stable cash flow while minimizing landlord responsibilities, as the tenant is responsible for taxes, insurance, operating expenses, and maintenance. The lease also includes 2.6 percent annual rent escalations, providing consistent income growth throughout the remaining primary lease term.
The facility supports highly specialized biologics manufacturing operations requiring tailored laboratory buildouts, advanced mechanical systems, and pharmaceutical-grade production infrastructure. GBI has invested approximately $26 million into the facility, demonstrating significant tenant commitment while creating substantial barriers to relocation.
The investment also offers a clear value-add component through the lease renewal structure. Upon the first renewal option, rent resets to 90 percent of prevailing market rent, representing over 40 percent mark-to-market rent upside based on current underwriting. This structure provides the ability to significantly increase income at the end of the primary term, producing a projected 9.84 percent cap rate in year seven.
Additionally, the property benefits from Florida’s recently enacted stem cell legislation, which allows certain regenerative treatments to be offered within the state and has helped increase demand for stem cell manufacturing capacity. GBI has indicated the expanded facility will support the production of up to one million stem cell units annually, positioning the asset within a rapidly growing segment of the biotechnology sector.
Property Facts
| Price | $14,115,914 CAD | Lot Size | 2.31 AC |
| Price Per SF | $372.34 CAD | Rentable Building Area | 37,911 SF |
| Sale Type | Investment NNN | No. Stories | 1 |
| Cap Rate | 6% | Year Built/Renovated | 1980/2023 |
| Property Type | Industrial | Tenancy | Single |
| Property Subtype | Warehouse | Parking Ratio | 3.1/1,000 SF |
| Building Class | B | No. Drive In / Grade-Level Doors | 1 |
| Zoning | I-LP, Plantation | ||
| Price | $14,115,914 CAD |
| Price Per SF | $372.34 CAD |
| Sale Type | Investment NNN |
| Cap Rate | 6% |
| Property Type | Industrial |
| Property Subtype | Warehouse |
| Building Class | B |
| Lot Size | 2.31 AC |
| Rentable Building Area | 37,911 SF |
| No. Stories | 1 |
| Year Built/Renovated | 1980/2023 |
| Tenancy | Single |
| Parking Ratio | 3.1/1,000 SF |
| No. Drive In / Grade-Level Doors | 1 |
| Zoning | I-LP, Plantation |
Amenities
- Bus Line
Major Tenants Click Here to Access
- Tenant
- Industry
- SF Occupied
- Rent/SF
- Lease Type
- Lease End
-
- Professional, Scientific, and Technical Services
-
99,999 SF
- -
-
Lorem Ipsum
-
Jan 0000
Goodwin Biotechnology offers you a Single Source Solution™ with a full range of mammalian cell culture development and manufacturing services ranging from the creation of up and downstream processes sufficient for the manufacturing of proof of concept or toxicology product material to processes for licensed manufacturing.
| Tenant | Industry | SF Occupied | Rent/SF | Lease Type | Lease End | |
|
|
Professional, Scientific, and Technical Services | 99,999 SF | - | Lorem Ipsum | Jan 0000 |
1 1
Fairly walkable
50/100
Very drivable
80/100
Limited public transit
30/100
Fairly bikeable
40/100
Property Taxes
| Parcel Number | 49-41-34-41-0090 | Improvements Assessment | $8,201,944 CAD |
| Land Assessment | $1,652,186 CAD | Total Assessment | $9,854,130 CAD |
Property Taxes
Parcel Number
49-41-34-41-0090
Land Assessment
$1,652,186 CAD
Improvements Assessment
$8,201,944 CAD
Total Assessment
$9,854,130 CAD
1 of 10
Videos
Matterport 3D Exterior
Matterport 3D Tour
Photos
Street View
Street
Map
1 of 1
Presented by
GBI Biomanufacturing HQ | 1850 NW 69th Ave
Already a member? Log In
Hmm, there seems to have been an error sending your message. Please try again.
Thanks! Your message was sent.